Jump to:    Scientific Posters                  Videos                  Whitepapers


Scientific Posters

Multi-Laboratory Assessment of a New Reference Material for Quality Assurance of Circulating Tumor DNA Measurements

NGS

Multi-Laboratory Assessment of a New Reference Material for Quality Assurance of Circulating Tumor DNA Measurements

BRCA1/2

NGS

Multi-site evaluation of novel BRCA1/2 reference materials including large genomic rearrangements

Comprehensive NGS-based reference materials for variant detection in lymphoid cancer

NGS

Reference Materials for the Development of Assays for the Detection of MRD in Acute Myeloid Leukemia

AACR 2023 HRD Poster

NGS

Multi-site evaluation of FFPE HRD Reference Materials

Comprehensive NGS-based reference materials for variant detection in lymphoid cancer

Cancer

Reference Materials for Analysis of BRCA1 and BRCA2 Gene Variants with Expansion to Large Genomic Rearrangements (LGRs) to Support Therapy Selection in Breast and Ovarian Cancer Patients

Comprehensive NGS-based reference materials for variant detection in lymphoid cancer

NGS

Seraseq FFPE Homologous Recombination Deficiency Reference Materials

Comprehensive NGS-based reference materials for variant detection in lymphoid cancer

NGS

Next Generation Reference Materials for Somatic Mutation Detection in Circulating Cell-Free DNA

Comprehensive NGS-based reference materials for variant detection in lymphoid cancer

ctDNA

Reference Materials for the Analysis of Methylation in Circulating Cell-Free DNA

Scientific Poster HRD

NGS

Development of Seraseq FFPE Homologous Recombination Deficiency Reference Materials for NGS Assay Validation

BRCA1/2

NGS

Multi-site evaluation of novel BRCA1/2 reference materials including large genomic rearrangements

Reference Materials for the Analysis of Methylation in Circulating Cell-Free DNA

ctDNA

Development of Seraseq ctDNA Myeloid Mutation Mix

The challenge of standardizing the measurement of an imprecise biomarker like HRD

NGS

The challenge of standardizing the measurement of an imprecise biomarker like HRD

Reference materials for ctDNA-based measurable residual disease (MRD) assay development and validation

ctDNA

Reference materials for ctDNA-based measurable residual disease (MRD) assay development and validation

Novel reference materials for the analysis of methylation in liquid biopsies

ctDNA

Novel reference materials for the analysis of methylation in liquid biopsies

Development of Blood TMB reference materials for validation of ccfDNA-based targeted NGS assays that measure tumor mutational burden in patient blood samples

bTMB

Development of Blood TMB reference materials for validation of ccfDNA-based targeted NGS assays that measure tumor mutational burden in patient blood samples

Development and performance of ctDNA based measurable residual disease reference materials

ctDNA

Development and performance of ctDNA based measurable residual disease reference materials

Reference Materials for the Analysis of Methylation in Circulating Cell-Free DNA

cfDNA

Reference Materials for the Analysis of Methylation in Circulating Cell-Free DNA

Reference Materials for Tumor Mutational Burden Transcriptome Profiling

TMB

Reference Materials for Tumor Mutational Burden Transcriptome Profiling

Optimizing Performance of Whole Transcriptome RNA-Seq Reference Materials

RNA

Optimizing Performance of Whole Transcriptome RNA-Seq Reference Materials

Development of Quality Control Reference Materials for MSI Testing

DNA

Development of Quality Control Reference Materials for MSI Testing

Reference Materials for Measurable Residual Disease (MRD) Monitoring in Circulating Cell-Free DNA

TMB

Reference Materials for Measurable Residual Disease (MRD) Monitoring in Circulating Cell-Free DNA

Development and performance of formalin-damaged FFPE reference materials

TMB

Development and performance of formalin-damaged FFPE reference materials

Development and validation of blood tumor mutational burden reference standards

bTMB

Development and validation of blood tumor mutational burden reference standards

Development and performance of a formalin-damaged multiplexed DNA tumor mutation FFPE reference material

TMB

Development and performance of a formalin-damaged multiplexed DNA tumor mutation FFPE reference material

Development of Reference Material for Blood Tumor Mutational Burden Measurement

TMB

Development of Reference Material for Blood Tumor Mutational Burden Measurement

Reference Materials for Measurable Residual Disease (MRD) Monitoring

TMB

Reference Materials for Measurable Residual Disease (MRD) Monitoring

Improving and Standardizing TMB Assay Performance

TMB

Improving and Standardizing TMB Assay Performance

Development of NTRK Reference Materials for Global Assay Standardization

TMB

Development of NTRK Reference Materials for Global Assay Standardization

Multi-Center Evaluation of Circulating Tumor DNA Assays

ctDNA

Multi-Center Evaluation of Circulating Tumor DNA Assays

Tumor Mutation Burden and Beyond: AACR Spotlight Webinar

RNA Fusion

Consistent Performance of Highly Multiplexed RNA Fusion Reference Materials Across Different NGS Assays in a Multi-Lab Studys

Interlaboratory Assessment of Complex Variant Detection

TMB

Interlaboratory Assessment of Complex Variant Detection

Comprehensive, Targeted NGS Method that Rapidly & Accurately Detects ctDNA Variants-0.1% Frequency in Plasma Samples

ctDNA

Comprehensive, Targeted NGS Method that Rapidly & Accurately Detects ctDNA Variants-0.1% Frequency in Plasma Samples   

New Technology to Generate Commutable and Comprehensive ctDNA Reference Materials for NGS

ctDNA

New Technology to Generate Commutable and Comprehensive ctDNA Reference Materials for NGS

Flexible Tools for Development & Performance Verification of Customized Target Enrichment Panels

NGS

Flexible Tools for Development & Performance Verification of Customized Target Enrichment Panels

Flexible Tools for Development & Performance Verification of Customized Target Enrichment Panels

ctDNA

Use of Highly Multiplexed Reference Materials Facilitate Validation of Clinical NGS Tumor Fusion RNA Assay

Multiplexed NGS Reference Material - IHT

NGS

Multiplexed Next-Generation Sequencing Reference (NGS) Materials for Testing of Inherited Disorders

Commutable ctDNA Reference Materials

ctDNA

A Commutable Circulating Tumor DNA (ctDNA) Reference Material

Development of Highly Multiplexed Reference Materials for Inherited Cancer Testing

TMB

Development of Highly Multiplexed Reference Materials for Inherited Cancer Testing

 




Videos

Methylated DNA Biomarkers

ctDNA

Methylated DNA Biomarkers Detected in Plasma for Early Cancer Screening and Diagnostics

Understanding and Clarifying the Complexities of HRD Measurement in Cancer

NGS

Understanding and Clarifying the Complexities of HRD Measurement in Cancer

Tumor Mutation Burden and Beyond: AACR Spotlight Webinar

TMB

Tumor Mutation Burden and Beyond: AACR Spotlight Webinars

The Promise of Liquid Biopsy Application to Cancer Disease Diagnostics and Therapeutic Monitoring

ctDNA

The Promise of Liquid Biopsy Application to Cancer Disease Diagnostics and Therapeutic Monitoring

Diagnostic Challenges in Cancer Immunotherapy Webinar

TMB

Diagnostic Challenges in Cancer Immunotherapy Webinar

New Tools and Strategies for High Quality TMB Analysis by NGS

TMB

New Tools and Strategies for High Quality TMB Analysis by NGS

Tumor Mutation Burden and Beyond: AACR Spotlight Webinar

RNA Fusion

Consistent Performance of Highly Multiplexed RNA Fusion Reference Materials Across Different NGS Assays in a Multi-Lab Studys

Multi-Center Evaluation of Circulating Tumor DNA Assays

ctDNA

Multi-Center Evaluation of Circulating Tumor DNA Assays

ONC_2019_03_Optimizing TMB Use in Cancer Research and Care

TMB

Workshop Video: Optimizing TMB Use in Cancer Research and Care: The Friends of Cancer Research TMB Harmonization Effort

Enabling Standardised Testing of Liquid Biopsy Assays Detecting EGFR Mutations Using Bespoke Reference Materials

EGFR

Enabling Standardised Testing of Liquid Biopsy Assays Detecting EGFR Mutations Using Bespoke Reference Materials

Designing Next-Generation Sequencing Controls and Standards for Optimal Quality and Performance

NGS QC

Designing Next-Generation Sequencing Controls and Standards for Optimal Quality and Performance

New Technology to Generate Commutable and Comprehensive ctDNA Reference Materials for NGS

ctDNA

New Technology to Generate Commutable and Comprehensive ctDNA Reference Materials for NGS

Flexible Tools for Development & Performance Verification of Customized Target Enrichment Panels

ctDNA

Use of Highly Multiplexed Reference Materials Facilitate Validation of Clinical NGS Tumor Fusion RNA Assay

 





White Papers

Development of a Novel Reference Material for MRD Monitoring Assays

ctDNA

Development of a Novel Reference Material for MRD Monitoring Assays

The critical role of NGS RM

NGS

The Critical Role of NGS Reference Materials in Precision Oncology Applications